Resveratrol

Resveratrol

SCHEMBL27900295

CCCC(=O)O.Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 5/20 0.61
▸ CYP1A1 P04798 5/20 0.61
▸ PTGS1 P23219 5/20 0.61
▸ KDM4E B2RXH2 4/20 0.61
▸ CYP1B1 Q16678 4/20 0.61
▸ LMNA P02545 3/20 0.61
▸ CA12 O43570 3/20 0.61
▸ CA1 P00915 3/20 0.61
▸ CA2 P00918 3/20 0.61
▸ CA7 P43166 3/20 0.61
▸ CA9 Q16790 3/20 0.61
▸ CA14 Q9ULX7 3/20 0.61
▸ MEN1 O00255 3/20 0.61
▸ MAPT P10636 3/20 0.61
▸ KMT2A Q03164 3/20 0.61
▸ CYP1A2 P05177 3/20 0.61
▸ TTR P02766 3/20 0.61
▸ ALOX5 P09917 3/20 0.61
▸ CYP19A1 P11511 3/20 0.61
▸ CA3 P07451 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resveratrol SCHEMBL27900294 0.91 ALB (0.62) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Stearic Acid SCHEMBL27900293 0.88 ALB (0.67) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Resveratrol SCHEMBL27882849 0.88 ALB (0.67) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Resveratrol SCHEMBL19331480 0.83 PTGS2 (0.70) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Resveratrol SCHEMBL21225662 0.83 PTGS2 (0.76) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Resveratrol SCHEMBL29473334 0.83 PTGS2 (0.76) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Resveratrol SCHEMBL28030055 0.83 PTGS2 (0.76) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Resveratrol SCHEMBL28719858 0.82 PTGS2 (0.83) PTGS2CYP1A1PTGS1KDM4ECYP1B1
Oleic Acid SCHEMBL28802198 0.82 ALB (0.60) PTGS1KDM4ELMNAMAPTKMT2A
Resveratrol SCHEMBL27963234 0.82 PTGS1 (0.54) PTGS2CYP1A1PTGS1KDM4ECYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090200-A1 POLYPHENOLIC DRUGS WITH SHORT-CHAIN FATTY ACIDS THE MEDICAL COLLEGE OF WISCONSIN, INC. (US) 2026-04-30 — — WO disclosed
CN-102802656-B Skin repair compositions comprising a synergistic combination of circadian gene activator and Sirt1 gene activator ELC MAN LLC 2014-09-03 — — CN disclosed
CN-102802656-A Skin repair compositions comprising a synergistic combination of circadian gene activator and Sirt1 gene activator ELC MAN LLC 2012-11-28 — — CN disclosed
Send feedback